Notice: Prescription Drug List (PDL): Vitamin D

Notice: Prescription Drug List (PDL): Vitamin D The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of Vitamin D on the Prescription Drug List (PDL) to allow non-prescription status for products a) containing up to 62.5 µg or 2,500 International Units (IU)/dosage form for oral use; or b) with a maximum recommended daily oral intake of 2,500 IU. Only the Human part of the PDL was revised. 2023-09-30 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetynotice of amendmentPrescription Drug ListPDLVitamine D Notice: Prescription Drug List (PDL): Vitamin DHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/notice-amendment-vitamin-d.html Notice: Prescription Drug List (PDL): Vitamin DHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-concernant-modifications/avis-modification-vitamine-d.html

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of Vitamin D on the Prescription Drug List (PDL) to allow non-prescription status for products a) containing up to 62.5 µg or 2,500 International Units (IU)/dosage form for oral use; or b) with a maximum recommended daily oral intake of 2,500 IU. Only the Human part of the PDL was revised.

Data and Resources

Similar records